← Back to Search

Other

Thymus Regeneration Therapy for Age-Related Immune Decline (TRIIM-X Trial)

Phase 2
Recruiting
Research Sponsored by Intervene Immune, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 40 to 80 years, inclusive
Be older than 18 years old
Must not have
Postmenopausal women on HRT
Premenopausal women
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a personalized mix of medicines to help regenerate the thymus, an important part of the immune system that weakens with age. The treatment includes a growth hormone, a diabetes drug (metformin), and a hormone supplement (DHEA). It aims to strengthen the immune system and possibly slow down aging in elderly people.

Who is the study for?
The TRIIM-X trial is for men and women aged 40 to 80, from any ethnicity, who can commit to a year-long study. It's not suitable for smokers, those with growth hormone deficiencies or high cancer risks, people on certain medications like steroids or HRT, anyone with serious heart conditions or uncontrolled diabetes, and premenopausal women.
What is being tested?
This trial tests a personalized treatment aiming to regenerate the thymus and improve immune function in older adults. It involves recombinant human growth hormone (somatropin), metformin, DHEA doses based on prior trials' safety data. The goal is to refine this regimen for broader use and validate biomarkers related to aging prevention.
What are the potential side effects?
Potential side effects may include reactions typical of growth hormones such as joint pain, swelling due to fluid retention (edema), muscle pain; metformin might cause digestive issues; DHEA could affect mood and energy levels. Individual responses can vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 40 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a postmenopausal woman currently on hormone replacement therapy.
Select...
I am a woman who has not gone through menopause.
Select...
I have a slow heart rate, high blood pressure, severe chest pain, or other serious heart conditions.
Select...
I have severe joint pain or swelling.
Select...
I have or might have growth hormone resistance.
Select...
I am currently taking medication for carbonic anhydrase inhibitors.
Select...
I have carpal tunnel syndrome.
Select...
I am on long-term steroid medication.
Select...
I am a smoker or not willing to quit smoking.
Select...
My thyroid is underactive and not treated.
Select...
I am HIV positive.
Select...
I do not have any unstable health conditions.
Select...
I am not willing to stop taking testosterone supplements even if my levels are high.
Select...
My PSA levels are high, not due to prostatitis.
Select...
I have been diagnosed with Type 1 or Type 2 diabetes.
Select...
I have a high risk of cancer due to my family history or past health issues.
Select...
I have skin growths that can't be treated with freezing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Epigenetic Age
Safety and Tolerability
Thymus Regeneration
Secondary study objectives
Immunosenescence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TRIIM TreatmentExperimental Treatment1 Intervention
Group II: Active ControlActive Control1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Age-Related Immune Decline, such as somatropin, metformin, and DHEA, work through different mechanisms to improve immune function. Somatropin stimulates growth and cell regeneration, aiding in thymic regeneration and enhancing immune responses. Metformin improves insulin sensitivity and has anti-aging effects, which can reduce inflammation and support immune health. DHEA, a precursor to sex hormones, has potential anti-aging properties that may bolster immune function. These treatments are significant for patients as they address the root causes of immune aging, potentially reversing immune decline and enhancing resistance to infections and age-related diseases.
The effect of hypophysectomy on thymic aging in mice.An aged immune system drives senescence and ageing of solid organs.Androgen supplementation improves some but not all aspects of immune senescence in aged male macaques.

Find a Location

Who is running the clinical trial?

Intervene Immune, Inc.Lead Sponsor

Media Library

DHEA (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04375657 — Phase 2
Age-Related Immune Decline Research Study Groups: TRIIM Treatment, Active Control
Age-Related Immune Decline Clinical Trial 2023: DHEA Highlights & Side Effects. Trial Name: NCT04375657 — Phase 2
DHEA (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04375657 — Phase 2
~17 spots leftby Dec 2025